Alerts will be sent to your verified email
Verify EmailTHEMISMED
|
Themis Medicare
|
Kopran
|
Shree Ganesh Remed.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
3.26 % | n/a | 3.15 % |
|
Financials
|
|||
|
5 yr Average ROE
|
15.48 % | 12.69 % | 20.54 % |
|
5yr average Equity Multiplier
|
1.56 | 1.57 | 1.34 |
|
5yr Average Asset Turnover Ratio
|
0.71 | 0.87 | 0.81 |
|
5yr Avg Net Profit Margin
|
13.75 % | 8.93 % | 19.4 % |
|
Price to Book
|
1.88 | 1.19 | 3.56 |
|
P/E
|
0.0 | 35.93 | 30.25 |
|
5yr Avg Cash Conversion Cycle
|
62.99 Days | 100.24 Days | 74.82 Days |
|
Inventory Days
|
69.58 Days | 84.74 Days | 56.37 Days |
|
Days Receivable
|
159.79 Days | 123.83 Days | 69.81 Days |
|
Days Payable
|
137.27 Days | 98.33 Days | 57.45 Days |
|
5yr Average Interest Coverage Ratio
|
7.27 | 10.74 | 37.3 |
|
5yr Avg ROCE
|
17.31 % | 17.11 % | 25.4 % |
|
5yr Avg Operating Profit Margin
|
18.07 % | 13.59 % | 28.41 % |
|
5 yr average Debt to Equity
|
0.28 | 0.22 | 0.17 |
|
5yr CAGR Net Profit
|
-3.53 % | -8.95 % | 29.89 % |
|
5yr Average Return on Assets
|
9.9 % | 7.93 % | 15.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.11 % | 44.42 % | 72.8 % |
|
Share Pledged by Promoters
|
2.43 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.07 % | 0.12 % | 4.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Themis Medicare
|
Kopran
|
Shree Ganesh Remed.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Verticals
|
Verticals
|
-
|
-
|